Navarra, Pierluigi
 Distribuzione geografica
Continente #
EU - Europa 6.881
NA - Nord America 5.740
AS - Asia 1.548
SA - Sud America 29
OC - Oceania 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.225
Nazione #
US - Stati Uniti d'America 5.686
DE - Germania 2.321
PL - Polonia 1.110
IT - Italia 988
SE - Svezia 849
CN - Cina 713
UA - Ucraina 473
SG - Singapore 411
FR - Francia 295
IE - Irlanda 246
GB - Regno Unito 235
ID - Indonesia 151
IN - India 130
FI - Finlandia 119
RU - Federazione Russa 100
TR - Turchia 54
BE - Belgio 42
CA - Canada 35
NL - Olanda 25
MX - Messico 19
IR - Iran 17
VN - Vietnam 17
JP - Giappone 16
ES - Italia 15
BR - Brasile 14
CZ - Repubblica Ceca 14
AU - Australia 13
CH - Svizzera 13
HK - Hong Kong 12
CL - Cile 9
GR - Grecia 7
KR - Corea 6
LT - Lituania 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
RO - Romania 5
IL - Israele 4
NO - Norvegia 4
DK - Danimarca 3
HU - Ungheria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
EU - Europa 2
GE - Georgia 2
IQ - Iraq 2
MN - Mongolia 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
EG - Egitto 1
HR - Croazia 1
KE - Kenya 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 14.225
Città #
Chandler 1.197
Warsaw 1.018
Ashburn 503
Jacksonville 317
Singapore 303
San Mateo 274
Dublin 246
Fairfield 228
Verona 227
Wilmington 223
Nanjing 201
Houston 187
Ann Arbor 181
Woodbridge 157
Jakarta 149
New York 148
Nürnberg 144
Cattolica 142
Milan 134
Seattle 132
Bremen 127
Dearborn 110
Rome 100
Munich 99
Kraków 88
Cambridge 87
Lawrence 85
Boston 82
Moscow 79
Nanchang 79
Marseille 76
Redwood City 63
Princeton 55
Chicago 54
Beijing 53
Izmir 47
Mountain View 43
Brussels 42
Lancaster 38
Hangzhou 35
Kunming 35
Boardman 33
Shenyang 32
University Park 32
Los Angeles 31
Jiaxing 30
Leawood 29
Fremont 27
Tianjin 25
Hebei 23
Pune 23
Changsha 21
Redmond 21
Philadelphia 20
Shanghai 19
Norwalk 18
San Diego 18
Helsinki 17
Zhengzhou 17
London 15
Dong Ket 14
Ottawa 14
Guangzhou 13
Phoenix 13
Busto Arsizio 12
Nutley 12
Toronto 12
Augusta 11
Hong Kong 11
Jinan 11
Falls Church 10
Paris 10
Scottsdale 10
Washington 10
Costa Mesa 9
Detroit 9
Monmouth Junction 9
Montesilvano Marina 9
Naples 9
Simi Valley 9
Andover 8
Ferrara 8
Frankfurt am Main 8
Athens 7
Brno 7
Hefei 7
Indiana 7
Sydney 7
Turin 7
Cagliari 6
Ciudad Nezahualcoyotl 6
Edinburgh 6
Florence 6
Kish 6
Lanzhou 6
Lappeenranta 6
Sandston 6
Abidjan 5
Amsterdam 5
Corchiano 5
Totale 8.385
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 357
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 351
mTOR kinase: a possible pharmacological target in the management of chronic pain 350
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 320
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of BCL-XL gene expression. 308
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 306
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 304
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 304
The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 261
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 210
The human microglial HMC3 cell line: where do we stand? A systematic literature review 192
The role of small intestinal bacterial overgrowth in Parkinson's disease 182
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 175
Effects of the administration of epidermal growth factor receptor specific inhibitor cetuximab, alone and in combination with cisplatin, on proliferation and apoptosis of Hep-2 laryngeal cancer cells 172
Full HTA di Emicizumab 172
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 157
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 156
Effects of remifentanil on human C20 microglial pro-inflammatory activation 149
Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both μ-opioid and nociceptin/orphanin peptide receptors. 142
Produzione in vitro e in vivo di interleuchina-1 dopo una convulsione febbrile 141
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 138
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 129
Antiretrovirals inhibit arginase in human microglia 128
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 126
Variability of raltegravir plasma levels in the clinical setting 125
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 125
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 121
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature 119
Stress-related biomarkers of dream recall and implicit memory under anaesthesia 119
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 119
Utilizzo degli antidepressivi e caratteristiche socio-economiche nelle regioni italiane. Evidenze da uno studio ecologico. 116
Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells 115
Impact of regional copayment policy on selective serotonin reuptake inhibitor (SSRI) consumption and expenditure in Italy 114
Pro-inflammatory activation of a new immortalized human microglia cell line 111
N-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. 110
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. 109
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 109
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 109
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 108
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 106
The impact of Regional co-payment and National reimbursement criteria on statins use in Italy: an interrupted time-series analysis 105
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 105
Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat 104
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 103
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem. 103
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 102
Antiretrovirals inhibit arginase in human microglia 102
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 101
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 100
Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. 100
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 100
Antinociceptive activity of buprenorphine and lumiracoxib in the rat orofacial formalin test: a combination analysis study. 99
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception 98
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 95
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 95
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 94
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 93
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 92
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 92
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 92
Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection. 89
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 88
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 88
Peripheral antinociceptive effects of low doses of naloxone in an in vivo and in vitro model of trigeminal nociception. 87
Prolactin-lowering ability of (+/-)-idazoxan may be linked to a central noradrenergic-serotonergic interplay 87
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 86
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 85
Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization 84
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 82
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 82
Molecular and pharmacological evidence for a facilitatory functional role of presynaptic GLUK2/3 kainate receptors on GABA release in rat trigeminal caudal nucleus. 82
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 82
Exploiting microglial functions for the treatment of glioblastoma 82
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells 82
Death due to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 81
beta-Carotene Downregulates the Steady-State and Heregulin-{alpha}-Induced COX-2 Pathways in Colon Cancer Cells. 80
A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon 79
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 79
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 79
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 78
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 77
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 76
Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol. 76
Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy. 76
Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients 75
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 75
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 74
P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals 74
Diffusion of complementary evolving pharmaceutical innovations: The case of Abacavir and its pharmacogenetic companion diagnostic in Italy 73
Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. 72
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 72
Pharmacokinetic profile of Oncofid-S after intraperitoneal and intravenous administration in the rat. 70
Exploiting Microglial Functions for the Treatment of Glioblastoma 70
Interactions between Integrase Inhibitors and human Arginase 1 69
A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials 69
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 68
Death to anaphylactic shock secondary to intravenous self-injection of Toradol: a case report and review of the literature. 67
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 66
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 66
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 65
Totale 12.132
Categoria #
all - tutte 53.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.271 0 0 0 0 137 164 194 99 185 106 243 143
2020/20211.436 77 157 24 151 171 74 216 34 188 99 204 41
2021/20221.711 149 112 26 102 120 64 42 235 72 96 429 264
2022/20233.106 356 452 241 520 243 367 115 271 345 48 93 55
2023/20241.630 89 396 66 153 82 219 118 54 30 57 182 184
2024/2025718 77 87 224 120 210 0 0 0 0 0 0 0
Totale 14.423